Magnetic resonance spectroscopy and its applications in psychiatry (Q30684591)

26 June 2017

1 reference

title

Magnetic resonance spectroscopy and its applications in psychiatry (English)

1 reference

26 June 2017

0 references

0 references

Michael Valenzuela

2

0 references

Perminder Sachdev

object named as

Perminder Sachdev

series ordinal

4

0 references

Gin Malhi

series ordinal

1

object named as

Gin S Malhi

1 reference

26 June 2017

Wei Wen

3

1 reference

26 June 2017

publication date

1 February 2002

1 reference

Australian and New Zealand Journal of Psychiatry

26 June 2017

published in

1 reference

26 June 2017

volume

36

1 reference

26 June 2017

issue

1

1 reference

26 June 2017

page(s)

31-43

1 reference

Brain imaging technologies: how, what, when and why?

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Clinical Neuroimaging in Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Magnetic resonance spectroscopy and schizophrenia: what have we learnt?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Factors affecting the quantification of short echo in-vivo 1H MR spectra: prior knowledge, peak elimination, and filtering

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Reproducibility of 1H-MRS in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Functional imaging studies: linking mind and basic neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

N-acetylaspartate in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Metabolism and role of glutamate in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Measurement of Glutamate and Glutamine in the Medial Prefrontal Cortex of Never-Treated Schizophrenic Patients and Healthy Controls by Proton Magnetic Resonance Spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Improvements on an in Vivo automatic shimming method (FASTERMAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Absolute metabolite quantification by in vivo NMR spectroscopy: I. Introduction, objectives and activities of a concerted action in biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Quality assessment in in vivo NMR spectroscopy: III. Clinical test objects: design, construction, and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Study of the maturation of the child's brain using 31P-MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

31P-NMR study of brain phospholipid structures in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Functional connectivity in depressive, obsessive-compulsive, and schizophrenic disorders: an explorative correlational analysis of regional cerebral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

From neuropathology to neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

The reduced neuropil hypothesis: a circuit based model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

MRI anatomy of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

The membrane hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Cerebral phosphate metabolism in first-degree relatives of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Magnetic resonance spectroscopy in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Platelet membrane phospholipids in euthymic bipolar disorder patients: are they affected by lithium treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Depression: a role for neurosurgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

The neuropathologic basis of major affective disorders: neuroanatomic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics--a study including 50 patients and 36 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Neuroimaging in bipolar disorder: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Signal transduction pathways. Molecular targets for lithium's actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Magnetic resonance spectroscopy in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

In vivo magnetic resonance spectroscopy of human brain: The biophysical basis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Prediction of cognitive decline in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Decreased glutamate glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Single-voxel 1H-MRS investigation of brain metabolic changes during lactate-induced panic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Effects of chronic alcohol consumption on the broad phospholipid signal in human brain: an in vivo 31P MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Evidence of multiple ethanol pools in the brain: an in vivo proton magnetization transfer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Metabolic changes in rat brain after prolonged ethanol consumption measured by 1H and 31P MRS experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

Ethanol in human brain by magnetic resonance spectroscopy: correlation with blood and breath levels, relaxation, and magnetization transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1440-1614.2002.00992.X

10.1046/J.1440-1614.2002.00992.X

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference